General Information
Impax Peds Migraine IPX229-B12-01
A Multicenter, Randomized, Double-Blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy and Safety of Zolmitriptan Nasal Spray for the Treatment of Acute Migraine in Subjects 6 to 11 Years, with an Open-Label Extension
| Protocol | IPX229-B16-01 |
|---|---|
| Identifier | |
| UID | a8300a82-3b65-4d68-8ac3-d452ce608e81 |
| Status | PI Declined |
| Phase | 3 |
| Category | Migraine / Adolescent |
| Launch Year | 0 |
| NCT Number | - |
| Created | 2017-12-22 15:45 |
| Last Updated | 2017-12-22 15:45 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | No | |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | No | |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Casaclang, Cecilia | CCasaclang | No |
| Recruiter | - | No | |
| Coordinator | - | No | |
| Regulatory | - | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Impax Laboratories, Inc |
|---|---|
| Division | Impax Laboratories, Inc |
| Team | Impax Laboratories, Inc |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gray |
| Currency | - |
